Shanghai, China

Haihua Yu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxo Group Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haihua Yu. Retrieved from https://idiyas.com/inventor/haihua-yu-12fuo84s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haihua Yu: Innovator in Therapeutic Compounds

Introduction

Haihua Yu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds aimed at treating diseases associated with Lp-PLA activity.

Latest Patents

Haihua Yu holds 1 patent related to his innovative work. His patent focuses on compounds that inhibit Lp-PLA activity, which are crucial in the treatment of conditions such as atherosclerosis and Alzheimer's disease. This invention represents a significant advancement in therapeutic options for these serious health issues.

Career Highlights

Yu is currently associated with Glaxo Group Limited, a leading global healthcare company. His work at Glaxo has allowed him to engage in cutting-edge research and development, contributing to the advancement of medical science.

Collaborations

Throughout his career, Haihua Yu has collaborated with notable colleagues, including Zehong Wan and Kai Long. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Haihua Yu's contributions to the field of medicinal chemistry and his innovative patent work highlight his role as a key figure in the development of new therapeutic compounds. His ongoing efforts continue to pave the way for advancements in treating critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…